Business Context and Reporting Period
This Form 8-K Current Report from Clarivate Analytics Plc covers events occurring on February 28, 2020, with the report filed on March 2, 2020. The filing details the completion of a strategic acquisition and associated financing activities.
Key Financial Metrics and Transactions
- Acquisition Consideration: Total cash consideration of $900.0 million for the acquisition of Decision Resources Group (DRG).
- Financing Structure:
- Approximately $540.0 million funded by net proceeds from an offering of 27.6 million ordinary shares (closed February 10, 2020).
- Remaining cash consideration, plus fees and expenses, funded by $360.0 million in incremental term loans and cash on hand.
- Deferred Equity Consideration: Agreement to issue up to 2,895,638 ordinary shares to the seller, valued at approximately $50.0 million as of January 17, 2020, to be issued one year post-closing.
- Debt: Entered into an Incremental Facility Amendment with Bank of America, N.A. and Citibank, N.A. for $360.0 million in aggregate principal amount.
Material Changes
The primary material change is the closing of the acquisition of Decision Resources Group (DRG), a provider of healthcare data and analytics, from Piramal Enterprises Limited. This transaction expands Clarivate's portfolio into the healthcare industry. Additionally, the company's capital structure changed significantly through the issuance of new equity and the incurrence of $360.0 million in new term debt.
Outlook, Risks, and Contingencies
- Deferred Share Issuance: The issuance of the ~2.9 million shares is contingent upon the resolution of certain claims against the seller, if any.
- Regulatory Filings: Clarivate agreed to file a registration statement to permit the seller to dispose of the deferred ordinary shares.
- Financial Reporting: Financial statements of the acquired business and pro forma financial information are scheduled to be filed by May 15, 2020.
- Debt Terms: The incremental term loans carry terms identical to the existing credit agreement dated October 31, 2019.
Investor Verification Checklist
- Verify the final number of ordinary shares to be issued to the seller, as this is subject to adjustment based on claim resolutions.
- Review the upcoming pro forma financial information (due May 15, 2020) to assess the impact of the $900 million cash outlay and $360 million debt on leverage ratios.
- Confirm the integration timeline and expected synergies of the DRG acquisition as detailed in the press release (Exhibit 99.1).
- Monitor the terms of the incremental facility amendment to ensure no covenants were triggered by the acquisition.